GUM GRAFTING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025 - 2032)

Global Gum Grafting Market Size and Forecast – 2025 to 2032

The Global Gum Grafting Market is estimated to be valued at USD 479.5 Mn in 2025 and is expected to reach USD 832.4 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.2% from 2025 to 2032. This steady growth reflects increasing awareness about oral health, advancements in dental membrane grafting materials, and a rising prevalence of periodontal diseases worldwide, driving the demand for effective gum grafting procedures.

Key Takeaways of the Global Gum Grafting Market

• In 2025, the Connective Tissue Graft (CTG) segment is expected to account for the largest share of the global gum grafting market at 42.5%.
• Within the material type segment, autografts procedures using the patient’s own tissue lead twith an estimated 40.2% of the market share in 2025.
• Among product types, biological membranes are expected to represent the dominant category, holding 24.5% of the market share in 2025.
• North America is expected to lead the market, holding a share of 38.3% in 2025. Asia Pacific is anticipated to be the fastest-growing region, with a market share of 23.4% in 2025.

Market Overview

Market trends indicate a growing preference for minimally invasive surgery and bioengineered grafting techniques that enhance patient outcomes and reduce recovery times. Additionally, the integration of digital technologies such as 3D imaging for precise diagnosis and treatment planning is gaining momentum. The expanding geriatric population and the surge in cosmetic dentistry further fuel the market growth, while ongoing research and development efforts continue to introduce innovative products, shaping the future landscape of gum grafting.

Current Events and Its Impact

Uncover macros and micros vetted on 75+ parameters: Get instant access to report

Segmental Insights

To learn more about this report, Download Free Sample

Gum Grafting Market Insights, By Procedure Type – Connective Tissue Graft (CTG) Leads  Owing to their Superior Clinical Outcomes

When it comes to the type of procedure, the Connective Tissue Graft (CTG) segment will occupy the highest share of 42.5% in 2025 due to its prevalence in clinical acceptance and success in addressing gingival recession and enhancing root coverage. The benefit of CTG is that it involves harvesting of the connective tissue located under the palate of the patient and then it is transplanted into the area of interest

In February 2024, a study by Marta Torra-Moneny at the University of Barcelona found that using connective tissue grafts during immediate implant placement helps maintain gum levels and improves aesthetics in gum grafting. Zimmer Biomet, a U.S. medical device firm, and Osstem Implant India, a major dental implant supplier, apply similar grafting methods to enhance treatment success.

Gum Grafting Market Insights, By Material Type – Autografts Highly Preferred Due to Their Superior Biocompatibility and Safety Profile

Based on material type, autografts, which includes the tissue of the patient, will add the most significant portion to the global gum grafting market, accounting for 40.2% of the market share in 2025. The main basis of this preference is the natural biocompatibility that autografts have, which can greatly lower chances of immune rejection as well as post operative complications.

The autograft method normally entails the excision of tissue in palate or other intra-oral locations, which harbors healthy connective tissue, which is fit to grafting. Although this procedure will need one more operation of tissue harvesting, it is worth this sacrifice because of improved patient outcomes. There is also no foreign material, which helps to ease the fears of transmitting diseases or over-reactions related to donor-derived or synthetic materials which gives the practitioners and the patients a sense of relief.

Gum Grafting Market Insights, By Product Type –Biological Membranes Dominate Due to their Role in Facilitating Regeneration

Biological membranes are expected to hold the largest market share of 24.5% in 2025 due to their necessity in directed tissue regeneration (GTR) and soft tissue repair. These membranes act as barriers that block epithelial cells from migrating into the grafted area. This allows periodontal ligament cells and fibroblasts the cells responsible for forming new tissue to selectively repopulate the site. As a result, tissue regeneration occurs in a more controlled and functional manner.

Colagen or other natural polymers are usually used to form biological membranes and have good biocompatibility and biodegradability. Their application complements an entire environment of bone and soft tissue regeneration that does not require consecutive removal surgeries, and it increases patient comfort and clinical performance.

Regional Insights

To learn more about this report, Download Free Sample

North America Gum Grafting Market Analysis and Trends

The gum grafting market in North America is supported by a well-established dental healthcare system, accounting for an estimated 38.3% in 2025. The region also benefits from strong familiarity with periodontal therapy and the presence of major industry players focused on developing advanced products and improved treatment methods. The fact that the region is enjoying favourable government policies on oral health promotion coupled with high levels of dental insurance coverage that enable patients to access elective oral health procedures like gum grafting is an added advantage.

For example, Justin M. Schlaikjer, DDS, MS Periodontics and Implant Dentistry, a specialized dental practice based in U.S., highlighted the growing adoption of gum grafting procedures to treat gum recession and prevent tooth loss. The clinic reported strong patient outcomes with improved comfort and esthetic balance through personalized grafting solutions such as connective tissue, free gingival, and lateral pedicle grafts.

Asia Pacific Gum Grafting Market Analysis and Trends

The Asia Pacific region is witnessing the fastest growth in the gum grafting market accounting for 23.4% in 2025, driven by an aging population, increasing awareness of dental health, and the expansion of healthcare infrastructure across emerging economies such as India and China. The rising middle-class with high disposable income is stimulating the need to have sophisticated dental services, including periodontal surgeries.

Additionally, the affordability of dental treatments in the region has made it a key destination for medical tourism, further boosting the market growth. The industry presence is expanding, with local companies innovating to meet rising domestic demand and international players entering the market to capitalize on the region’s untapped potential.

Gum Grafting Market Outlook for Key Countries

U.S. Gum Grafting Market Trends

The U.S. market for gum grafting is well developed and has an established dental care system, insurance coverage, and significant levels of awareness among patients regarding cosmetic and functional advantages of gum grafting. Major manufacturers like Dentsply Sirona and Straumann have large operations in this country provided a wide range of grafting material and surgery technology. Their unrelenting efforts in clinical research and surgeon education programs help them penetrate the market.

For example, in February 2025, Millennium Dental Technologies, a U.S.-based innovator in dental laser systems, announced it had received a new U.S. patent for its laser-assisted periodontal treatment technology. The company, known for developing the LANAP protocol and manufacturing the PerioLase MVP-7 laser, continues to advance minimally invasive gum grafting and periodontal regeneration methods.

Germany Gum Grafting Market Trends

The German gum grafting market is characterized by well-developed healthcare facilities and strict government regulations governing medical devices, ensuring that gum grafting products and procedures consistently meet high standards of safety, precision, and quality. This strong regulatory and clinical foundation has positioned Germany as a leading center for advanced periodontal care and innovation in Europe. The nation enjoys a wide insurance reimbursement of periodontal treatments, which have increased access by the patients and created a constant market demand.

Leading European dental companies, such as Geistlich Pharma headquartered in Switzerland but highly active in Germany play a crucial role in supplying biomaterials and collagen matrices used in gum grafting procedures. Their strong presence and expertise significantly support the region’s clinical advancements and product quality standards within the gum grafting market.

China Gum Grafting Market Trends

China is becoming an important market in the Asia Pacific region with increased dental health awareness, growth in urban middle classes, and government initiatives that facilitate oral healthcare cover. Local firms are also growing and producing cost effective gum grafting material that can meet local demand and multinationals like Zimmer Biomet and Henry Schein have also grown distribution and partnering. In addition to that, the development of the chains of dental services and specialization centers in big cities promotes the use of the modern periodontal procedures.

For example, Zimmer Biomet operates in China through its Shanghai office, offering graft and biologic products for periodontal repair. Henry Schein distributes dental supplies across major cities such as Beijing and Guangzhou, strengthening access to advanced gum grafting materials. Beijing Biosis Healing develops affordable graft membranes and biomaterials tailored for domestic clinics, supporting local adoption and innovation in gum grafting solutions.

India Gum Grafting Market Trends

The gum grafting market in India is growing with the support of rising dental tourism, rising awareness about periodontal diseases, and the expanding infrastructure of private dental care. Availability of grafting materials that are afforded by domestic firms, as well as international firms that come in through joint ventures helps the market grow. Improvement in regulation and government efforts towards the enhancement of oral health services available in rural states further facilitate access to periodontal services.

For example, Osstem Implant India Pvt. Ltd., a subsidiary of OSSTEM IMPLANT India Pvt Ltd., has been operating in India since 2006. It provides dental implant solutions and related biomaterials, with operations in Mumbai and Gurgaon.

End user Feedback and Unmet Needs for the Global Gum Grafting Market

• End user feedback in the global gum grafting market reflects a mix of satisfaction and persistent challenges across dental clinics, hospitals, and specialty centers. Many practitioners emphasize the improved success rates and patient outcomes achieved through advanced grafting materials, such as acellular dermal matrices and xenografts. For instance, dental specialists in North America report that minimally invasive grafting techniques have significantly reduced patient recovery times and postoperative discomfort, improving clinic efficiency and patient satisfaction. However, some users particularly in emerging markets cite recurring issues with the high cost of biomaterials, limited local supplier availability, and the need for more hands-on training to ensure consistent procedural outcomes, especially in complex cases like multiple recession defects.
• Despite advancements in graft materials and surgical techniques, several unmet needs continue to limit broader adoption. Users express demand for more cost-effective, ready-to-use graft materials, better integration with digital imaging and surgical planning systems, and improved long-term clinical data on newer bioengineered products. There is also growing interest in customized or regenerative alternatives that reduce the need for autografts while maintaining durability and esthetic outcomes. Addressing these gaps could unlock major opportunities for manufacturers enabling stronger penetration in price-sensitive regions, fostering innovation in biomaterial design, and improving long-term user loyalty through enhanced procedural outcomes and ease of use.

Market Players, Key Developments, and Competitive Intelligence

To learn more about this report, Download Free Sample

Key Developments

• On October 09, 2025, Cedars-Sinai, a leading U.S. healthcare and research institution, announced a new study aimed at improving gum grafting and oral tissue regeneration through stem cell technology. Supported by a USD 5.7 million National Institutes of Health grant, the project brings together Cedars-Sinai Guerin Children’s, Virginia Commonwealth University, and the University of California, San Francisco.
• In April 2025, Dental Instruments, a leading provider of dental solutions, shared insights on effective treatments for gum recession. The company emphasized how gum grafting and laser therapy are improving outcomes for patients, helping restore healthy gum lines and reduce tooth sensitivity through early detection and modern dental care.
• In April 2025, the National University of Singapore (NUS), a leading global research university, announced a breakthrough in gum grafting using artificial intelligence and 3D bioprinting to create personalized gum tissue grafts. Led by Assistant Professor Gopu Sriram from the NUS Faculty of Dentistry, the project developed an AI-driven workflow that accelerates oral tissue fabrication while reducing surgical invasiveness.
• In September 2024, Regenity Biosciences, a global regenerative medicine company backed by Linden Capital Partners, received approval from China’s NMPA for its Matrixflex collagen dental membrane following a landmark clinical study. Conducted across six major hospitals, the study compared Matrixflex with Geistlich’s Bio-Gide membrane and found stronger tissue integration and faster healing in gum grafting and periodontal regeneration.

Top Strategies Followed by Global Gum Grafting Market Players

• The established market leaders are making significant investments in research and development (R&D) to create high-performance, clinically effective products that align with the emerging trends in dental healthcare. Such firms focus on high level of integration of material science and technology to make grafting materials, which enhance patient outcomes and efficiency of surgery. To further cement their authority, the established players develop strategic alliances and collaboration with key stakeholders in the industry and original equipment manufacturers (OEMs) so that they can capitalize on mutually complimentary experience and resource sharing.
  • For example, Geistlich Pharma (Switzerland) pioneers collagen-based soft-tissue matrices like Mucograft and Fibro-Gide, backed by strong clinical data. Straumann Group (Switzerland) integrates biologics such as Emdogain with guided-tissue protocols and OEM kits. botiss biomaterials (Germany) supplies mucoderm and Jason membrane for tunnel and coronally advanced flap workflows with broad KOL adoption. ZimVie (U.S.) offers Puros Dermis and peri-implant soft-tissue kits aligned to implant workflows in hospitals and dental service organizations.

• The mid-level players in the gum grafting market focus on reaching price-sensitive consumers by offering cost-effective yet reliable solutions. Their strategy aims to balance quality and affordability, ensuring that gum grafting procedures are more accessible to both patients and dental practitioners seeking economical treatment options without compromising clinical effectiveness.
  • For example, ACE Surgical Supply (U.S.) manufactures value-priced collagen membranes, sutures, and grafting sets for routine mucogingival surgery. Bioteck SpA (Italy) produces porcine-derived collagen matrices and membranes sized for quadrant cases at accessible price points. Tecnoss OsteoBiol (Italy) delivers pericardium-based barriers and soft-tissue matrices used in CAF + CTG combinations by cost-conscious clinics.

• The strategy of small-scale participants in the global gum grafting market involves targeting niche segments that require specialized functionalities or innovative product products. These businesses frequently use state-of-the-art technology in the form of bioengineered grafting materials, least invasive delivery methods, or innovative biomaterials to draw the attention of specific consumer segments and dental experts.
  • For example, Snoasis Medical (U.S.) focuses on amnion-chorion allograft patches (BioXclude) for minimally invasive recession coverage and peri-implant thickening. Collagen Matrix Inc (U.S.) specializes in dentist-ready collagen soft-tissue matrices with single-site sizing to reduce waste. BIOLASE (U.S.) manufactures diode and based dental lasers that enable laser-assisted soft-tissue grafting with reduced morbidity.

Market Report Scope

Gum Grafting Market Report Coverage

Gum Grafting Market Dynamics

To learn more about this report, Download Free Sample

Gum Grafting Market Driver - Rising Prevalence of Periodontal Diseases

The rising prevalence of periodontal diseases in the world today is one of the major forces behind the need of gum grafting operation. Periodontal diseases are diseases that are caused by inflammation and infection of gums, causing deterioration of the soft tissue and bone which support teeth, which usually causes recession of the gums. This recession not only affects the beauty of the teeth but it makes the teeth sensitive and prone to other oral complications like cavities and loss of teeth. As awareness of the importance of oral health grows, there is an increasing demand for services that focus on treating gum tissue and preventing oral health issues. This shift is driving the need for more advanced surgical procedures, including gum grafting, to address and maintain healthy gum tissue.

In March 2025, the World Health Organization, a leading global health agency, reported that oral diseases affect nearly 3.7 billion people worldwide and remain a growing concern despite being largely preventable. The organization highlighted that conditions such as gum disease, tooth decay, and oral cancers are increasing due to high sugar consumption, tobacco and alcohol use, and limited access to dental care. WHO emphasized that early prevention, public awareness, and improved treatment access are essential to reduce the global burden of oral diseases and strengthen care frameworks like gum grafting for long-term oral health.

Gum Grafting Market Opportunity - Development of Novel Biomaterials and Growth Factors

The global gum grafting market presents significant opportunities due to the advancements in biomaterials and growth factors used in gum grafting procedures. These innovations are enhancing the effectiveness and success of gum grafting surgeries, particularly for restoring gum tissue and addressing recession in the oral cavity. Biomaterials like bioactive scaffolds, collagen matrices, and synthetic polymers are improving the efficacy, safety, and patient outcomes of gum grafting surgeries. The materials are more biocompatible, heals quicker, and has less postoperative complications, leading to increased use by dental professionals. Also, the use of growth factors such as platelet-derived growth factor (PDGF), bone morphogenetic proteins (BMPs), and enamel matrix derivatives (EMDs) in grafting procedures is transforming the current technology of tissue regeneration by promoting cell growth and differentiation.

In August 2023, RevBio Inc., a biotechnology company specializing in regenerative bone adhesives, received the U.S. FDA approval to begin its second U.S. clinical trial for dental implant stabilization using its advanced Tetranite formulation. The new pH-modified, porous version of Tetranite promotes faster bone substitution and improved integration, offering significant benefits for gum grafting and implant dentistry.

Analyst Opinion (Expert Opinion)

• The gum grafting market is growing due to slow but steady adoption of the technology. However, its demand is still limited by cost, uneven supply of specialists, learning curves, and patchy reimbursement among others. The soonest opportunities are presented by digital planning, custom grafting, peri-implant soft-tissue bundles for DSOs, and medical tourism hubs aligning clinical pathways with payers.
• Partially through forums and meetings like the American Academy of Periodontology Annual Meeting, Academy of Osseointegration Annual Meeting, IADR General Session, and IDS Cologne. These events focus on discussing protocols, biomaterial advancements, and payer trends, which shape the knowledge and adoption of new gum grafting techniques and treatment methods. The real-world movement in the dental community includes the DSO implementation of the mucosal-thickening pathways that are intertwined with hygiene recalls, the expansion of the adult Medicaid dental benefit in several U.S. states since 2023, and the ongoing collaboration between manufacturers and universities that focuses on comparing ADM and collagen matrices with CTG using standardized patient-reported outcomes that inform upcoming guidelines.

Market Segmentation

• Procedure Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Connective Tissue Graft (CTG)
  • Free Gingival Graft (FGG)
  • Pedicle Graft (Lateral Pedicle)
  • Acellular Dermal Matrix (ADM) Allograft
  • Tissue-Engineered Grafts
• Material Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Autografts (Patient's Own Tissue)
  • Allografts (Human Donor Tissue)
  • Xenografts (Animal-Derived Tissue, e.g., Bovine/Porcine)
  • Alloplasts (Synthetic Materials)
• Product Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Biological Membranes
  • Collagen Matrices
  • Tissue Scaffolds
  • Bone Graft Substitutes
  • Regenerative Biomaterials
• Indication Insights (Revenue, USD Mn, 2020 - 2032)
  • Gingival Recession Coverage (Teeth)
  • Peri-implant Soft-Tissue Augmentation
  • Keratinized Tissue Width Increase
  • Ridge/Soft-Tissue Thickening Pre-Prosthetics
  • Mucogingival Defects post-Orthodontics/Trauma
• Age Group Insights (Revenue, USD Mn, 2020 - 2032)
  • Pediatric/Adolescent
  • Adult
  • Geriatric
• End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals
  • Dental Clinics
  • Academic and Research Institutes
  • Ambulatory Surgical Centers
• Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
• Key Players Insights
  • Geistlich Pharma AG
  • Dentsply Sirona
  • Straumann Group
  • botiss biomaterials GmbH
  • BioHorizons
  • CAMLOG Biotechnologies GmbH
  • ZimVie
  • Collagen Matrix Inc.
  • Osteogenics Biomedical Inc.
  • Datum Dental Ltd.
  • Sunstar GUIDOR
  • Integra LifeSciences
  • Bioteck S.p.A.
  • Purgo Biologics
  • Nobel Biocare

Sources

Primary Research Interviews

• Industry Stakeholders List
  • Periodontists and oral surgeons
  • Dental implant specialists
  • Biomaterial manufacturers (R&D heads)
  • Academic researchers in periodontology
  • Dental association representatives
  • Dental technology consultants
• End-Users List
  • Multi-specialty dental clinics
  • Hospital dental departments
  • Independent periodontal practices
  • Dental service organizations (DSOs)
  • Dental schools and teaching hospitals
  • Patients undergoing soft-tissue grafting

Government and International Databases

• World Health Organization (WHO) Oral Health Database
• U.S. Food and Drug Administration (FDA) Medical Device Database
• Centers for Disease Control and Prevention (CDC) Oral Health Division
• National Institutes of Health (NIH) PubChem and MedlinePlus
• European Medicines Agency (EMA)
• National Health Service (NHS) Digital Oral Health Reports

Trade Publications

• Dental Tribune International
• Compendium of Continuing Education in Dentistry
• Dental Economics
• Inside Dentistry
• Dentistry Today
• Dental Product Shopper

Academic Journals

• Journal of Periodontology
• Clinical Oral Implants Research
• Journal of Clinical Periodontology
• International Journal of Periodontics & Restorative Dentistry
• Journal of Dental Research
• Journal of Oral and Maxillofacial Surgery

Reputable Newspapers

• The New York Times Health Section
• The Guardian Health
• The Washington Post Science Section
• Financial Times Health & Life Sciences
• Reuters Health News
• Bloomberg Healthcare

Industry Associations

• American Academy of Periodontology (AAP)
• European Federation of Periodontology (EFP)
• International Association for Dental Research (IADR)
• Academy of Osseointegration (AO)
• FDI World Dental Federation
• American Dental Association (ADA)

Public Domain Resources

• ScienceDirect Open Access
• ResearchGate Open Access Repository
• National Library of Medicine (NLM)
• World Dental Federation Oral Health Atlas

Proprietary Elements

• CMI Data Analytics Tool: Proprietary analytics tool to analyze real-time market trends, consumer behavior, and technology adoption in market
• Proprietary CMI Existing Repository of Information for Last 8 Years